Furthermore, in breast cancer, the BMP4–SMAD7 signalling axis blocks tumour metastasis, and increased levels of BMP4 and SMAD7 predicted improved recurrence-free survival and OS in breast cancer patients [122]. Here, SMAD7 is linked to breast carcinoma.